BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30808726)

  • 1. Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin.
    Sun K; Jiang P; Cheng SH; Cheng THT; Wong J; Wong VWS; Ng SSM; Ma BBY; Leung TY; Chan SL; Mok TSK; Lai PBS; Chan HLY; Sun H; Chan KCA; Chiu RWK; Lo YMD
    Genome Res; 2019 Mar; 29(3):418-427. PubMed ID: 30808726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation.
    Ivanov M; Baranova A; Butler T; Spellman P; Mileyko V
    BMC Genomics; 2015; 16 Suppl 13(Suppl 13):S1. PubMed ID: 26693644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidimensional fragmentomic profiling of cell-free DNA released from patient-derived organoids.
    Kim J; Hong SP; Lee S; Lee W; Lee D; Kim R; Park YJ; Moon S; Park K; Cha B; Kim JI
    Hum Genomics; 2023 Oct; 17(1):96. PubMed ID: 37898819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing.
    van der Pol Y; Tantyo NA; Evander N; Hentschel AE; Wever BM; Ramaker J; Bootsma S; Fransen MF; Lenos KJ; Vermeulen L; Schneiders FL; Bahce I; Nieuwenhuijzen JA; Steenbergen RD; Pegtel DM; Moldovan N; Mouliere F
    EMBO Mol Med; 2023 Dec; 15(12):e17282. PubMed ID: 37942753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered cfDNA fragmentation profile in hypomethylated regions as diagnostic markers in breast cancer.
    Wang J; Niu Y; Yang M; Shu L; Wang H; Wu X; He Y; Chen P; Zhong G; Tang Z; Zhang S; Guo Q; Wang Y; Yu L; Gou D
    Epigenetics Chromatin; 2023 Sep; 16(1):33. PubMed ID: 37740218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology.
    Stanley KE; Jatsenko T; Tuveri S; Sudhakaran D; Lannoo L; Van Calsteren K; de Borre M; Van Parijs I; Van Coillie L; Van Den Bogaert K; De Almeida Toledo R; Lenaerts L; Tejpar S; Punie K; Rengifo LY; Vandenberghe P; Thienpont B; Vermeesch JR
    Nat Commun; 2024 Mar; 15(1):2220. PubMed ID: 38472221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization.
    Bie F; Wang Z; Li Y; Guo W; Hong Y; Han T; Lv F; Yang S; Li S; Li X; Nie P; Xu S; Zang R; Zhang M; Song P; Feng F; Duan J; Bai G; Li Y; Huai Q; Zhou B; Huang YS; Chen W; Tan F; Gao S
    Nat Commun; 2023 Sep; 14(1):6042. PubMed ID: 37758728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic biases in reference-based plasma cell-free DNA fragmentomic profiling.
    Liu X; Yang M; Hu D; An Y; Wang W; Lin H; Pan Y; Ju J; Sun K
    Cell Rep Methods; 2024 Jun; 4(6):100793. PubMed ID: 38866008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring.
    Li S; Zeng W; Ni X; Liu Q; Li W; Stackpole ML; Zhou Y; Gower A; Krysan K; Ahuja P; Lu DS; Raman SS; Hsu W; Aberle DR; Magyar CE; French SW; Han SB; Garon EB; Agopian VG; Wong WH; Dubinett SM; Zhou XJ
    Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2305236120. PubMed ID: 37399400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematically Evaluating Cell-Free DNA Fragmentation Patterns for Cancer Diagnosis and Enhanced Cancer Detection via Integrating Multiple Fragmentation Patterns.
    Hou Y; Meng XY; Zhou X
    Adv Sci (Weinh); 2024 Jun; ():e2308243. PubMed ID: 38881520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cell-free DNA fragmentation is a stepwise and conserved process linked to apoptosis.
    Zhu D; Wang H; Wu W; Geng S; Zhong G; Li Y; Guo H; Long G; Ren Q; Luan Y; Duan C; Wei B; Ma J; Li S; Zhou J; Mao M
    BMC Biol; 2023 Nov; 21(1):253. PubMed ID: 37953260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasma.
    Che H; Jiang P; Choy LYL; Cheng SH; Peng W; Chan RWY; Liu J; Zhou Q; Lam WKJ; Yu SCY; Lau SL; Leung TY; Wong J; Wong VW; Wong GLH; Chan SL; Chan KCA; Lo YMD
    Genome Res; 2024 Mar; 34(2):189-200. PubMed ID: 38408788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement Biases Distort Cell-Free DNA Fragmentation Profiles and Define the Sensitivity of Metagenomic Cell-Free DNA Sequencing Assays.
    Chang A; Mzava O; Lenz JS; Cheng AP; Burnham P; Motley ST; Bennett C; Connelly JT; Dadhania DM; Suthanthiran M; Lee JR; Steadman A; De Vlaminck I
    Clin Chem; 2021 Dec; 68(1):163-171. PubMed ID: 34718476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and Characterization of Cell-Free DNA from Cerebral Organoids.
    Silver BB; Brooks A; Gerrish K; Tokar EJ
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Reliable Method for Quantifying Plasma Cell-Free DNA Using an Internal Standard Strategy: Evaluation in a Cohort of Non-Pregnant and Pregnant Women.
    Cepeda J; Racca ME; Rossetti MF; Cardozo MA; Gaydou L; Luque EH; Muñoz-de-Toro M; Milesi MM; Varayoud J; Ramos JG
    Reprod Sci; 2024 Apr; 31(4):987-996. PubMed ID: 38030813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery.
    Penny L; Main SC; De Michino SD; Bratman SV
    Biochem Cell Biol; 2024 Mar; ():. PubMed ID: 38478957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling clinical DNA fragmentation in the development of universal PCR-based assays for bisulfite-converted, formalin-fixed and cell-free DNA sample analysis.
    Johnston AD; Lu J; Korbie D; Trau M
    Sci Rep; 2022 Sep; 12(1):16051. PubMed ID: 36163372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA.
    Liu Y; Reed SC; Lo C; Choudhury AD; Parsons HA; Stover DG; Ha G; Gydush G; Rhoades J; Rotem D; Freeman S; Katz D; Bandaru R; Zheng H; Fu H; Adalsteinsson VA; Kellis M
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Sequencing of Human Satellite 2 Repeat Sequences in Plasma cfDNA Reveals Potential Breast Cancer Biomarkers.
    Gezer U; Oberhofer A; Worf K; Stoetzer O; Holdenrieder S; Bronkhorst A
    Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches for detecting cancer with circulating cell-free DNA.
    Fiala C; Diamandis EP
    BMC Med; 2019 Aug; 17(1):159. PubMed ID: 31416458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.